Healy AM - Search Results

1

Engineering Oral and Parenteral Amorphous Amphotericin B Formulations against Experimental Trypanosoma cruzi Infections.

Rolón M, Serrano DR, Lalatsa A, de Pablo E, Torrado JJ, Ballesteros MP, Healy AM, Vega C, Coronel C, Bolás-Fernández F, Dea-Ayuela MA. Rolón M, et al. Among authors: healy am. Mol Pharm. 2017 Apr 3;14(4):1095-1106. doi: 10.1021/acs.molpharmaceut.6b01034. Epub 2017 Mar 3. Mol Pharm. 2017. PMID: 28198632 Free article.

2

Particle engineering of materials for oral inhalation by dry powder inhalers. I-Particles of sugar excipients (trehalose and raffinose) for protein delivery.

Ogáin ON, Li J, Tajber L, Corrigan OI, Healy AM. Ogáin ON, et al. Among authors: healy am. Int J Pharm. 2011 Feb 28;405(1-2):23-35. doi: 10.1016/j.ijpharm.2010.11.039. Epub 2010 Dec 1. Int J Pharm. 2011. PMID: 21129458

3

Particle engineering of materials for oral inhalation by dry powder inhalers. II-Sodium cromoglicate.

Nolan LM, Li J, Tajber L, Corrigan OI, Healy AM. Nolan LM, et al. Among authors: healy am. Int J Pharm. 2011 Feb 28;405(1-2):36-46. doi: 10.1016/j.ijpharm.2010.11.040. Epub 2010 Dec 1. Int J Pharm. 2011. PMID: 21129460

4

A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.

Caron V, Tajber L, Corrigan OI, Healy AM. Caron V, et al. Among authors: healy am. Mol Pharm. 2011 Apr 4;8(2):532-42. doi: 10.1021/mp1003674. Epub 2011 Mar 3. Mol Pharm. 2011. PMID: 21323367

5

Evaluation of HPβCD-PEG microparticles for salmon calcitonin administration via pulmonary delivery.

Tewes F, Gobbo OL, Amaro MI, Tajber L, Corrigan OI, Ehrhardt C, Healy AM. Tewes F, et al. Among authors: healy am. Mol Pharm. 2011 Oct 3;8(5):1887-98. doi: 10.1021/mp200231c. Epub 2011 Sep 15. Mol Pharm. 2011. PMID: 21882837

6

Investigation of the capacity of low glass transition temperature excipients to minimize amorphization of sulfadimidine on comilling.

Curtin V, Amharar Y, Hu Y, Erxleben A, McArdle P, Caron V, Tajber L, Corrigan OI, Healy AM. Curtin V, et al. Among authors: healy am. Mol Pharm. 2013 Jan 7;10(1):386-96. doi: 10.1021/mp300529a. Epub 2012 Dec 5. Mol Pharm. 2013. PMID: 23186332

7

Formation and physicochemical properties of crystalline and amorphous salts with different stoichiometries formed between ciprofloxacin and succinic acid.

Paluch KJ, McCabe T, Müller-Bunz H, Corrigan OI, Healy AM, Tajber L. Paluch KJ, et al. Among authors: healy am. Mol Pharm. 2013 Oct 7;10(10):3640-54. doi: 10.1021/mp400127r. Epub 2013 Aug 30. Mol Pharm. 2013. PMID: 23947816

8

Impact of alternative solid state forms and specific surface area of high-dose, hydrophilic active pharmaceutical ingredients on tabletability.

Paluch KJ, Tajber L, Corrigan OI, Healy AM. Paluch KJ, et al. Among authors: healy am. Mol Pharm. 2013 Oct 7;10(10):3628-39. doi: 10.1021/mp400124z. Epub 2013 Sep 6. Mol Pharm. 2013. PMID: 23961942

9

Polymorphism in sulfadimidine/4-aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties.

Grossjohann C, Serrano DR, Paluch KJ, O'Connell P, Vella-Zarb L, Manesiotis P, Mccabe T, Tajber L, Corrigan OI, Healy AM. Grossjohann C, et al. Among authors: healy am. J Pharm Sci. 2015 Apr;104(4):1385-98. doi: 10.1002/jps.24345. Epub 2015 Jan 20. J Pharm Sci. 2015. PMID: 25605031 Free article.

10

Emerging Nanonisation Technologies: Tailoring Crystalline Versus Amorphous Nanomaterials.

Serrano DR, Gallagher KH, Healy AM. Serrano DR, et al. Among authors: healy am. Curr Top Med Chem. 2015;15(22):2327-40. doi: 10.2174/1568026615666150605122917. Curr Top Med Chem. 2015. PMID: 26043733 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters